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Fluoroquinolone (FQ) agents are a potential resort to treat infection due to
Enterobacteriaceae producing extended spectrum β-lactamase and susceptible
to FQ. In a context of increase of non-susceptibility to carbapenems among
Enterobacteriaceae, we characterized FQ resistance mechanisms in 75 Enterobacter
cloacae isolates non-susceptible to ertapenem in North-Eastern France in 2012 and
describe the population structure by pulsed field gel electrophoresis (PFGE) and multi-
locus sequence typing (MLST). Among them, 14.7% (12/75) carried a carbapenemase-
encoding gene. Except one isolate producing VIM-1, the carbapenemase-producing
isolates carried the well-known IncL/M pOXA48a plasmid. Most of the isolates (59/75)
harbored at least a FQ-R determinant. qnr genes were predominant (40%, 30/75). The
MLST study revealed that E. cloacae isolates’ clonality was wide [24 different sequence
types (STs)]. The more widespread STs were ST74, ST101, ST110, ST114, and ST133.
Carbapenem MICs were higher for E. cloacae ST74 than for other E. cloacae isolates.
Plasmid-mediated quinolone resistance determinants were more often observed in
E. cloacae ST74 isolates. These findings showed that (i) pOXA-48a is spreading in
North-Eastern France, (ii) qnr is preponderant in E. cloacae, (iii) E. cloacae comprised a
large amount of lineages spreading in North-Eastern France, and (iv) FQ as an alternative
to β-lactams to treat ertapenem non-susceptible Enterobacteriaceae are compromised.
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INTRODUCTION
Enterobacter cloacae complex is, together with Escherichia coli, very common human
Enterobacteriaceae pathogens. They can be a reservoir for infection due to their intestine
colonization in patients upon long-term hospitalization and antimicrobial treatment. Due to the
β-lactams antibiotic intensive use, rate of Enterobacteriaceae resistant to lactams-lactams highly
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increased these last years in French hospitals (Carbonne et al.,
2013). Carbapenems are one of the last lines to treat patients
infected with multidrug resistant Enterobacteriaceae. Thus,
decreased susceptibility to carbapenems represents a threat
of therapeutic dead ends. Two main mechanisms lead to
decrease the susceptibility to carbapenems in Enterobacteriaceae
isolates: (i) production of carbapenemase or (ii) production of
other β-lactamase in combination with decreased permeability
(Nordmann et al., 2011).
In France, OXA-48 is the most prevalent carbapenem-
hydrolyzing β-lactamase and is a public health concern (Poirel
et al., 2012b; Robert et al., 2014).
Recently in France, ﬂuoroquinolone (FQ) agents have been
proposed as the ﬁrst choice to treat FQ-susceptible extended-
spectrum β-lactamase-producing enterobacterial (ESBL) isolates
in pyelonephritis in order to spare carbapenems1. Then,
FQ can be used to treat infections due to carbapenem
non-susceptible isolates. However, plasmid-mediated quinolone
resistances (PMQR) confer a low level of quinolone resistance
and they were shown to signiﬁcantly reduce the activity of
ciproﬂoxacin in urinary (Allou et al., 2009; Guillard et al., 2013)
and respiratory (Rodríguez-Martínez et al., 2008; Dominguez-
Herrera et al., 2013) tract infection murine models. Multi-
locus sequence typing (MLST) has been widely used to study
population structure of E. coli and K. pneumoniae. Although
MLST has also been described for E. cloacae, only few studies are
available (Miyoshi-Akiyama et al., 2013; Izdebski et al., 2014).
The aim of this study was to characterize FQ resistance
determinants carried by E. cloacae isolates showing a non-
susceptibility to carbapenems and to assess the population
structure of these isolates in order to better understand their
spread in French hospitals.
MATERIALS AND METHODS
Selection of Bacterial Strains
The survey was conducted in the ﬁve teaching hospitals (UH1:
Besançon, UH2: Dijon, UH3: Nancy, UH4: Reims, and UH5:
Strasbourg) and two general hospitals (GH1: Colmar and GH2:
Troyes) in North-Eastern France from January 1st to June 30th,
2012. Medical data settings of the seven hospitals together were
10,311 beds and almost 540,000 admissions per year all through
the period of investigation. After detection on chromIDR© ESBL
agar plates (bioMérieux, Marcy l’Etoile, France), all non-duplicate
E. cloacae isolates from clinical or screening samples non-
susceptible to ertapenem (MIC ertapenem >0.5 μg/mL) were
collected and sent to Reims Hospital laboratory.
Identification, Susceptibility Testing, and
ESBL Detection
Identiﬁcation of isolates was performed using MALDI-TOF
(Bruker Daltonics, Bremen, Germany). Antibiotic susceptibilities
were determined by the disk diﬀusion method according to
European Committee on Antimicrobial Susceptibility Testing
1http://www.infectiologie.com
(EUCAST) guidelines2 and ESBLs were detected by the double-
disk synergy test as previously described (Jarlier et al., 1988; Duval
et al., 2009). AmpC overexpression was detected by disk diﬀusion
method performed on Mueller-Hinton agar supplemented with
cloxacillin (250 μg/mL). Carbapenem (imipenem, ertapenem,
doripenem, and meropenem) and FQ (norﬂoxacin, oﬂoxacin,
nalidixic acid, and ciproﬂoxacin) MICs were determined using
E test R© strips (bioMérieux, Marcy l’Etoile, France) according to
the manufacturer’s recommendations and interpreted according
to EUCAST. Metallo-β-lactamase production was screened with
the MβL E test (bioMérieux, Marcy l’Etoile, France). In addition,
metallo-β-lactamase was detected with imipenem disk with and
without EDTA (5 μL of 0.5 M EDTA per disk) as previously
described (Liapis et al., 2014).
β-Lactamase Detection
Carbapenemase-encoding genes blaKPC, blaVIM, blaIMP, blaNDM,
blaOXA−23-like, blaOXA−24-like, blaOXA−58-like, and blaOXA−48-
like were screened using multiplex PCRs and completed with
simplex PCRs for blaIMI and blaGES as described elsewhere
(Gharout-Sait et al., 2014). All the blaOXA−48-like detected
were subsequently sequenced. Genes blaTEM, blaSHV, blaCTX−M,
and blaOXA were detected by PCR using speciﬁc primers and
sequenced as previously described for all the ESBL-producing
strains (Guillard et al., 2014a). Plasmid-mediated AmpC-type
genes blaACC, blaFOX, blaMOX, blaDHA, blaCMY, and blaMIR were
screened using multiplex PCRs and sequenced as previously
described (Gharout-Sait et al., 2014).
Quinolone Resistance Determining
Region (QRDR) and PMQR Identification
The quinolone resistance determining region (QRDR) was
ampliﬁed by PCR and sequenced in the gyrA, gyrB, parC, and
parE genes, as described elsewhere (de Lastours et al., 2012). qnr,
qepA, and oqxAB genes were detected by real-time PCR, aac(6’)-
Ib-cr was detected by pyrosequencing as described elsewhere
(Guillard et al., 2010, 2011, 2015).
Contribution of Efflux and Reduced
Outer-membrane Permeability
For contribution of eﬄux and reduced outer-membrane
permeability study, we randomly selected ﬁve strains that did not
produce OXA-48 and three, which produced OXA-48.
Quantitative real-time reverse transcriptase PCR (qRT-PCR)
was performed to determine the expression of ompF and ompC
porin genes and the acrB eﬄux pump gene, relative to the rpoB
housekeeping gene. From bacteria grown to mid-exponential
growth phase in LB, total RNA was extracted using RNeasy
Kit (Qiagen, Courtaboeuf, France) as recommended by the
manufacturer. Residual chromosomal DNA was removed by
treating samples with the RNAase free DNase I (Qiagen) and
TURBO DNA-free kit (Life Technologies). DNase-treated RNA
samples were quantiﬁed using the easy-to-use QubitTM 3.0
Fluorometer (ThermoFisher Scientiﬁc). qRT-PCR experiments
2www.EUCAST.org
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were performed using the KAPA SYBR R© FAST One-Step
qRT-PCR Kit Universal (Kapa Biosystems, USA) and the
LightCycler 480 (Roche Molecular Diagnostics, Germany)
according to manufacturers’ recommendations. Each experiment
was performed in triplicate. RNA transcript levels were calculated
using the 2−Ct method following the MIQE checklist (Bustin
et al., 2009), and are expressed relative to levels in the E. cloacae
CIP 60.85T control. Primers used are presented in Supplementary
Table S1.
Bacterial outer-membrane proteins (OMPs) were detected by
SDS/PAGE as previously described (Martínez-Martínez et al.,
2002). Brieﬂy, bacterial cells were broken by sonication, and
membranes were collected by ultracentrifugation at 100,000 × g
for 1 h. The inner membrane was solubilized with 1% sodium
N-lauroylsarcosinate. Proteins in the outer membrane were
separated by SDS/PAGE and gels were stained with Coomassie
blue for visualization.
Plasmids Characterization
Plasmids carrying blaOXA−48 were studied as described
elsewhere (Guillard et al., 2014b). Brieﬂy, plasmid extraction
was performed by the Kieser method. Transfer of the plasmids
was then studied by conjugation assays using azide-resistant
E. coli J53 as a recipient cell and counter-selection with
ertapenem 0.5 μg/mL, rifampicin 250 μg/mL, and sodium
azide 100 μg/mL. Incompatibility groups of the plasmids
were eventually determined using the PCR-based replicon
typing (PBRT) for the paired strains and transconjugants
(Carattoli et al., 2005). The incL/M group was characterized
using the primers described by Poirel et al. (2012a). Genetic
environment of blaOXA−48 was studied by PCR mapping to seek
for an environment such as Tn1999.2 using primers listed in
Supplementary Table S1.
Genotyping
Pulsed-ﬁeld gel electrophoresis (PFGE) was performed on
E. cloacae isolates using the XbaI restriction enzyme as previously
described and results were interpreted according to international
criteria (Tenover et al., 1995).
Analysis of MLST Data
Multi-locus sequence typing was performed according to
published protocols (Diancourt et al., 2005; Miyoshi-Akiyama
et al., 2013). Clonal complexes (CC) were deﬁned as a group of
STs sharing at least ﬁve loci. In order to build a dendrogram
with the 373 sequence types (STs) available at the time of
the study (including the new ST described in this collection),
we concatenated the sequences of seven MLST genes to form
a 3,511-bp sequences alignment, deﬁning 914 polymorphic
positions. The best-ﬁt nucleotide substitution model for this
data was GTR + G + I, as determined with jModelTest
0.1.1. We used the Enterobacter aerogenes KCTC2190 as the
outgroup strain. Maximum likelihood tree was constructed
with RAxML 7.2.8 and visualized with Dendroscope 3.2.10
(Stamatakis, 2006; Huson and Scornavacca, 2012). In every
case, 1000 bootstrap repetitions gave values above 900 for most
branches.
Statistical Analysis
Qualitative variables were analyzed with the Chi2 test and
the two-tailed Fisher exact test. Quantitative variables were
compared using the Mann–Whitney test. The results were
considered statistically signiﬁcant when P < 0.05.
RESULTS
Species Distribution of the Ertapenem
Non-susceptible Enterobacteriaceae
Isolates
The 75 E. cloacae isolates were distributed as follow in the
diﬀerent centres: 21 (28.0%) in UH4, 18 (24.0%) in UH3, 13
(17.3%) in GH2, 10 (13.3%) in UH5, 9 (12.0%) in UH1, 3
(4.0%) in UH2, and 1 (1.3%) in GH1. They were isolated from
clinical samples (65.3%; n = 49: 22 (29.3%) urines, 5 (6.7%)
blood, 22 (29.3 %) other infectious sites) or from 26 screening
samples (34.7%; stools or rectal swabs). The global prevalence
of carbapenem-non-susceptible isolates in E. cloacae species was
6.05% (0.91–8.36 according to the centre).
Antibiotic Susceptibility and Level of
Resistance
All isolates but three were intermediate or resistant to piperacillin
and all but one to ticarcillin–clavulanic acid. Ten point seven
percent were susceptible to piperacillin–tazobactam, 4.0% to
aztreonam, 6.7% to cefotaxime, 22.7% to cefpirome, 46.7 to
cefepime, 33.3% to tobramycin, 38.7% to gentamicin, 96.0% to
amikacin, 52.7% to tetracycline, 45.9% to chloramphenicol, 17.3%
to nalidixic acid, 18.7% to oﬂoxacin, 26.7% to ciproﬂoxacin,
18.7% to norﬂoxacin, 57.3% to co-trimoxazole, 92.0% to
fosfomycin, 93.3% to imipenem, 97.3% tomeropenem, and 96.0%
to doripenem. The frequency of isolates susceptible to FQ agents
among clinical isolates did not diﬀer from that of screening
isolates (Table 1).
β-Lactam Resistance Determinants
Carbapenemases were not the major determinant leading
to decrease susceptibility to carbapenems in E. cloacae
isolates. Indeed, among them, 84% (63/75) did not produce
a carbapenemase. Nonetheless, among the carbapenemase-
producing isolates, OXA-48 (11/12 for E. cloacae) was the most
prevalent carbapenemase, and interestingly the majority of
OXA-48-producing isolates co-harbored CTX-M-15 and TEM-1
(11/11). One isolate produced VIM-1.
Focusing on isolates, which did not produce a carbapenemase,
most of them (40/63) did not produce ESBL, and 29 out of
63 did not produce any acquired β-lactamases. These strains
did not carry any plasmid-mediated AmpC-type genes except
one harboring blaDHA−1. The eight strains, studied for eﬄux
and porins expression, produced an overexpressed AmpC except
one. This latter did not produce any acquired β-lactamases.
ErtapenemMICs> 3mg/L were related to a decreased expression
of ompF and ompC, and for three strains with a lost a porin
(Table 2).
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TABLE 1 | FluoroquinolonesMIC (μg/mL) among the clinical and the screening Enterobacter cloacae isolates.
Nalidixic acid Norfloxacin Ciprofloxacin Ofloxacin
n MIC50 MIC90 Range MIC50 MIC90 Range MIC50 MIC90 Range MIC50 MIC90 Range
Screening isolates 26 >256 >256 3−>256 >256 >256 0,125–>256 >32 >32 0,016–>32 > 32 >32 0,125–>32
Clinical isolates 49 >256 >256 0,19−>256 12 >256 0,064–>256 2 >32 0,012–>32 8 >32 0,094–>32
Urines 22 >256 >256 2−>256 9 >256 0,064–>256 2 >32 0,012–>32 6 >32 0,094–>32
TABLE 2 | Contribution of efflux and reduced outer membrane permeability to carbapenems for E. cloacae strains resistant to ertapenem.
Strain ST β-lactamases MIC (μg/mL) SDS PAGE Relative expressiona
Ertapenem Imipenem Doripenem Meropenem ompF ompC acrB
12 01 033 133 SHV-12, CTX-M-9,
overexpressed AmpC
>32 16 4 6 Loss of OmpC 0.22 0.02 0.51
12 01 040 133 SHV-12, CTX-M-9,
overexpressed AmpC
>32 12 4 12 Loss of OmpC 0.23 0.03 0.7
12 05 006 175 SHV-12, overexpressed
AmpC
32 2 0.75 1 Loss of OmpF 0.05 0.11 2.28
12 03 029 74 CTX-M-15 2 2 0.5 2 – 0.44 0.22 2.76
12 06 020 102 – 1.5 2 1.5 1.5 – 0.52 0.36 2.12
12 05 004 74 OXA-48, CTX-M-15 6 1.5 0.75 1.5 – 3.15 0.54 9
12 03 022 110 OXA-48, CTX-M-15 3 1 0.75 0.5 Modified porins 3.23 0.009 6.57
12 03 028 74 OXA-48, CTX-M-15 2 1 0.25 0.75 - 0.44 0.22 2.76
aRelative expression is calculated as –2Ct, where Ct = (Cttarget – Ctreference). The targets were each strain studied and the reference was the reference strain
E. cloacae CIP 60.85T.
TABLE 3 | Mutations observed in QRDR of E. cloacae isolates.
Amino acid substitutions No. of isolates
(Total of 75)
GyrA ParC
Ser/Thr83 Asn87 Ser80
– – – 20
Ile – – 19
Ile – Ile 1
Phe – – 11
Phe – Ile 1
Phe Asn – 2
Phe Asn Ile 10
Phe Gly Ile 3
Leu – Ile 1
Tyr – – 6
Tyr His Ile 1
(–) Indicates no mutation found at the location.
All the strains co-producing OXA-48 and CTX-M-15 were
susceptible to carbapenems but ertapenem, with MICs close to
the breakpoints. The three OXA-48 and CTX-M-15-producing
strains, selected for eﬄux and outer membrane study, showed an
acrB overexpression of at least a twofold change (Table 2). All
these strains showed also a decreased ompC expression.
blaOXA−48 is Carried by an IncL/M
Conjugative Plasmid
To study plasmids carrying blaOXA−48, we selected three strains
to be studied among the E. cloacae OXA-48 producing-isolates
TABLE 4 | Prevalence of QRDR mutations in PMQR-carrying and PMQR
negative E. cloacae isolatesa.
E. cloacae PMQR+ PMQR–
QRDR+ 19 82.6% 24 60.0%
QRDR– 4 16.4% 16 40.0%
0 mutation 4 17.4% 16 40.0%
1 mutation 17 74.0% 9 22.5%
2 mutations 2 8.6% 2 5.0%
3 mutations 0 0.0% 13 32.5%
Total 23 40
aAfter exclusion of duplicates: one isolate was included in each PFGE harboring
different PMQR and mutations pattern in QRDR compared to the other isolates
included in the same PFGE profile.
according to antibiotic resistance genes characterization. Mating
out assays and plasmid DNA analysis allowed identiﬁcation of
a 62-kb-long plasmid carrying blaOXA−48 but not blaTEM−1 and
blaCTX−M−15. This conjugative plasmid belonged to the incL/M
incompatibility group. Mapping of the genetic environment
showed that blaOXA−48 was embedded in Tn1999.2 as previously
described (Poirel et al., 2004). As expected, OXA-48-producing
transconjugants showed a low level of resistance to carbapenems
(data not shown).
FQ Resistance Determinants
Most of the E. cloacae (59/75, 78.7%) isolates harbored a FQ-R
determinant. E. cloacae isolates carried in the same proportion
either substitutions in QRDR only (37%, 28/75) or association
of PMQR and substitutions in QRDR (36%, 27/75). Very few
isolates produced PMQR solely (5%).
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Focusing on PMQR harbored by the E. cloacae isolates, we
showed that only qnr genes and aac(6’)-Ib-cr were detected. qnr
genes were predominant (40%, 30/75) compared to aac(6’)-Ib-cr
(23%, 17/75), (P < 0.02). Three qnr families were found (qnrA,
qnrB, and qnrS) with a majority of qnrB (18/30). Looking more
carefully at the alleles, we found 9 qnrA1, 16 qnrB1, 2 qnrB2 and
3 qnrS1. Of the 31 PMQR-harboring E. cloacae isolates, 13 (42%)
carried qnr only and 17 (55%) qnr associated with aac(6’)-Ib-cr.
One was AAC(6’)-Ib-cr producer only.
Substitutions in the QRDR were detected at high rate.
Our ﬁndings showed that 73% (55/75) of isolates carried
substitutions in QRDR. Majority of isolates (51%, 38/75)
harbored substitutions in GyrA only. More precisely, E. cloacae
isolates carried predominantly either one substitution in GyrA
(48%, 36/75) or a combination of two substitutions in GyrA and
one substitution in ParC (18.7%, 14/75). The GyrA substitutions
Ser/Thr83Phe and Ser/Thr83Ile (49 and 36%, respectively) were
the most frequent (Table 3). No substitutions were characterized
in gyrB and parE.
As shown in Table 4, 82.6% of PMQR-producing E. cloacae
had substitution in QRDR vs. 60.0% in PMQR-negative. But the
number of substitutions in QRDR was higher in PMQR-negative
isolates (e.g., 3 mutations: 32.5% vs. 0% for PMQR-negative and
PMQR-producing isolates, respectively, P < 0.0001). For this
analysis, we deleted duplicates in each PFGE if they carried same
PMQR associated to same mutations pattern in QRDR.
Epidemiological Links of E. cloacae
Typing results of E. cloacae isolates are shown in Table 5.
Seventy-four isolates (one was untypeable with PFGE) were
distributed into 40 pulsotypes and the 75 isolates clustered
into 24 STs of which 12 were grouped into ﬁve CCs (CC42,
CC74, CC114, CC133, and CC234). ST74 was the most frequent
ST accounting for 16 out of 75 isolates (21%), followed by
ST101 (nine isolates, 12%) ST110 and ST133 (eight isolates
each, 11%) and ST114 (six isolates, 8%). Eight STs were split
into two to ﬁve pulsotypes and the two most predominant STs,
ST74 and ST101, were also the most diverse. The phylogenetic
tree built from the sequence data of the seven MLST genes
of the 373 STs of E. cloacae clearly showed that the great
majority of our isolates clustered in one phylogenetic group
(Figure 1).
Enterobacter cloacae ST74 isolates were more often less
susceptible than the other E. cloacae isolates to various
antimicrobial agents (Table 6). They included nine of the 11
OXA-48 producing isolates observed.
Plasmid-mediated quinolone resistances determinants were
more frequent in E. cloacae ST74 isolates than in non-ST74 (87%
vs. 40% P = 0.001). 81% (13/16) of ST74 isolates harbored qnr
vs. 29 % (17/58) of non-ST74 (P = 0.0002). Seventy-ﬁve percent
(12/16) of ST74 isolates contained aac(6’)-Ib-cr vs. 9% (5/58) of
non-ST74 (P = 4.10−7).
Ten of the 16 ST74 isolates were observed in GH2. They shared
the same pulsotype 32, produced the identical β-lactamases and
PMQR (CTX-M-15, TEM-1, QnrB1, and AAC(6’)-Ib-cr) and 8 of
them produced OXA-48. It appears that the spread of blaOXA−48
in E. cloacae was mainly due to an epidemic strain.
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FIGURE 1 | Distribution of the STs of 75 clinical isolates of Enterobacter cloacae (non-susceptible to carbapenems and isolated in North-Eastern
France) on a dendrogram built with the data all known STs (n = 373). (A) Overview of the dendrogram with E. aerogenes as outgroup. (B) Close-up of the
branch with ST179 and ST180. (C) Close-up the branch harboring the rest of the isolates described in this study. Enzymes in the different ST are represented with
blue (SHV/TEM), yellow (OXA-48), green (CTX-M), and red (VIM) spots. Spots’ size depends on the amount of strains.
DISCUSSION
Although FQ use has been reported recently as a risk factor for
infections due to carbapenem-resistant K. pneumoniae (Hussein
et al., 2009), French guidelines for urinary tract infection
treatment stated that FQ remains the ﬁrst line treatment for
pyelonephritis due to non-producing or producing-ESBL but FQ-
susceptible enterobacterial isolates. These guidelines should help
to decrease unnecessary carbapenem use to treat ESBL-producing
enterobacterial isolates. So, we decided to study FQ resistance
mechanisms in Enterobacteriaceae isolates non-susceptible to
carbapenems in North-Eastern France: (i) we determined
carbapenem susceptibility and β-lactamase detection; (ii) we
characterized PMQR and mutations in QRDR for E. cloacae; and
(iii) we deﬁned the population structure of E. cloacae isolates.
β-Lactam Resistance Determinants
Carbapenemases were not the major determinant leading to
decrease susceptibility to carbapenems in E. cloacae isolates.
Nonetheless, OXA-48 was the most prevalent carbapenamase.
All the strains co-harboring OXA-48 and CTX-M-15 were
susceptible to carbapenems but ertapenem, with MICs close
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to the breakpoints. But interestingly, contribution of eﬄux
and/or reduced outer membrane permeability was important in
those strains. Reports about carbapenem non-susceptibility of
E. cloacae were scarce and OXA-48-producing E. cloacae were
rarely reported (Hammoudi et al., 2014; Majewski et al., 2014;
Pantel et al., 2014). Then, the amount of OXA-48 E. cloacae
isolates in our study showed increase of this carbapenemase in
this species in France. In opposite to Hammoudi et al. (2014)
report in Lebanon, carbapenemase production is not the major
cause of carbapenem non-susceptibility in our isolates. The part
played by ESBL or AmpC was previously reported and DHA-1
has been shown to reduce imipenem activity combined with loss
of porins (Mammeri et al., 2010). This latter point is underscored
by our results showing combination of overexpressed eﬄux and
outer membrane impermeability for all the strains we sampled.
FQ Resistance Determinants
To our knowledge, few epidemiological studies have recently
reported data about PMQR and/or substitutions in QRDR in
E. cloacae, while huge data are available for E. coli. Majority of
the E. cloacae isolates harbored a FQ-R determinant. E. cloacae
isolates carried in the same proportion either substitutions in
QRDR only (37%), or association of PMQR and substitutions
in QRDR (36%). Very few isolates produced PMQR solely (5%).
These ﬁndings are diﬀerent from those reported by Ferjani
et al. (2014) stating that E. cloacae strains, isolated in 2010
in Tunisia, carried predominantly qnr genes (50%) but less
substitutions in QRDR (50%). Recently, it has been shown that
E. cloacae non-susceptible to carbapenem isolated in China from
2009 to 2012 were highly PMQR carriers (68.9%), but no data
about QRDR were available (Huang et al., 2012). Our results
about eﬄux and outer membrane permeability conﬁrmed that
reduced outer membrane permeability and increased eﬄux are
an important mechanism of FQ resistance in E. cloacae, as
previously reported for this specie (Davin-Regli and Pagès, 2015;
Li et al., 2015). Moreover as suggested by Davin-Regli and Pagès
(2015) this particular property could be an asset for spreading
in hospitals. We did not test all the strains for impermeability
but regarding of the results we obtained from the sampled
strains, overexpression of eﬄux pumps might be consider as
a major resistance determinant in E. cloacae (Davin-Regli and
Pagès, 2015). It has been proposed that OmpC disappears before
OmpF in E. aerogenes in the presence of selective pressure from
antibiotics and could be extend to other Enterobacteriaceae {de
Champs et al., 1993ce, Lavigne et al., 2013wz}. It is noteworthy
that our results are in agreement with this statement except for
one strain, which lacked OmpF and had a decreased expression
of OmpC. Similar results have been also reported for E. cloacae
without any clear information about this discrepancy {Doumith
et al., 2009ks}.
qnr is the Major PMQR Determinant in
E. cloacae
Focusing on PMQR harbored by the E. cloacae isolates, we
showed that only qnr genes and aac(6’)-Ib-cr were detected. qnr
genes were predominant (40%, 30/75) and qnrB was the most
predominant family.
TABLE 6 | Susceptibility rates of E. cloacae isolates to various
antimicrobials according to the ST type.
No. of susceptible isolates (%)
Antimicrobial agent ST74 Other ST P-value
n (%) n (%)
Ticarcillin + Clavulanic acid 0 (0.0) 1 (1.7) NS
Piperacillin + Tazobactam 2 (12.5) 6 (10.2) NS
Aztreonam 0 (0.0) 3 (5.1) NS
Cefotaxime 2 (12.5) 3 (5.1) NS
Ceftazidime 2 (12.5) 2 (3.4) NS
Cefepime 4 (25.0) 31 (52.5) 0.05
Cefpirome 3 (18.8) 14 (23.7) NS
Ertapenem 0 (0.0) 0 (0.0) NS
Imipenem 15 (93.8) 55 (93.2) NS
Meropenem 16 (100.0) 57 (96.6) NS
Doripenem 16 (100.0) 56 (94.9) NS
Tobramycin 2 (12.5) 23 (39.0) 0.04
Gentamicin 3 (18.8) 26 (44.1) NS (0.06)
Amikacin 14 (87.5) 58 (98.3) NS
Tetracycline 10 (62.5) 29 (50.0) NS
Chloramphenicol 3 (18.8) 31 (53.4) 0.05
Nalidixic acid 0 (0.0) 13 (22.0) NS
Ofloxacin 1 (6.3) 13 (22.0) NS
Ciprofloxacin 1 (6.3) 19 (32.2) 0.05
Co-trimoxazole 2 (12.5) 41 (69.5) <0.001
Fosfomycin 15 (93.8) 54 (93.1) NS
In a study conducted on ESBL-producing Enterobacteriaceae
in Tunisia, it has been shown that qnr genes were mainly detected
in E. cloacae (50%) and aac(6’)-Ib-cr genes in E. coli (47.5%)
isolates (Ferjani et al., 2014). Huang et al. studied the prevalence
of PMQR among carbapenem non-susceptible E. cloacae isolated
between 2009 and 2012 in China (Huang et al., 2012). From the
986 isolates, 35 (3.55%) were non-susceptible to carbapenem. In
their study, qnr geneswere detected in 75% of the isolates whereas
only 15% carried aac(6’)-Ib-cr.
E. cloacae Isolates have a Wide Range of
Substitutions Patterns
Substitutions in the QRDR were detected at high rate in the
E. cloacae isolates (73%) studied here. Majority of isolates (51%)
harbored substitutions in GyrA only, with Ser/Thr83Phe and
Ser/Thr83Ile (49 and 36%, respectively) as the most frequent.
These results diﬀered from those previously reported for E. coli,
stating that the GyrA substitution Ser83Leu is the most prevalent
substitution in QRDR (Fendukly et al., 2003). As no substitutions
were characterized in gyrB and parE, our ﬁndings underscored
that gyrB and parE substitutions in E. cloacae are very rare.
Indeed, these results were mostly described in E. coli isolates
(Uchida et al., 2010), but our ﬁndings suggest a similar trend for
E. cloacae.
GyrA substitutions were observed predominantly as single
substitution in QRDR in E. cloacae, but ParC mutations were
always combined with GyrA substitution. These results are in
Frontiers in Microbiology | www.frontiersin.org 7 October 2015 | Volume 6 | Article 1186
Guillard et al. FQ-resistance and MLST in E. cloacae
agreement with others studies and with the hypothesis that, in
Enterobacteriaceae, DNA gyrase is the primary target enzyme
where substitutions occur to resist against FQ. Topoisomerase
IV, described as less sensitive to FQ than DNA gyrase, is the
secondary target (Hooper, 2001). First-step quinolone resistance
mutations occur in gyrA and mutations in parC occurred as a
secondary event leading to highly resistant Enterobacteriaceae
isolates.
The aims of our study were not to determine contribution
of QRDR substitution to resistance, but it is well known
that substitutions in hot spot of QRDR lead to high
level of resistance as observed in this study (Hooper,
2001).
PMQR-negative E. cloacae Isolates
Harbor Multiple Substitutions in QRDR
Impact of PMQR on substitution in QRDR under FQ pressure
is still debating. Of course, in literature this issue was mainly
studied for qnr. In one hand, it has been largely reported
that Qnr proteins increase rate of substitution in QRDR by
increasing the mutant selection concentration. But, in the other
hand, it has been also observed in E. cloacae that fewer QRDR
substitutions occurred in Qnr-producing isolates (Lascols et al.,
2007). That was consistent with molecular analysis showing
that Qnr protects QRDR, in gyrase and Topoisomerase IV,
from substitution under FQ inhibition (Cesaro et al., 2008). So,
we looked eventually at the prevalence of QRDR substitutions
in PMQR-containing and PMQR-negative E. cloacae isolates
trying to gain insight how QRDR substitutions are aﬀected by
presence of PMQR. Our ﬁndings seem to support the hypothesis
that presence of PMQR may confer a low-level resistance
promoting at least one substitution in QRDR. Although,
harboring no PMQR seems to lead to multiple substitutions
in QRDR. We could hypothesize that a strain carrying no
PMQR may acquire one chromosomal substitution in GyrA
under FQ pressure. Then, if the strain carries at least Qnr, this
latter may avoid multiple substitutions by protecting QRDR
domains.
Epidemiological Links of E. cloacae
Typing results of E. cloacae isolates showed ST74 as the most
frequent ST with the lowest susceptibility against β-lactams and
carrying PMQR frequently.
To our knowledge, very few E. cloacae clonality studies are
available. Recently, a multinational study performed on 195
rectal carriage isolates, revealed several epidemic CC, such as
CC74 and CC114 (Izdebski et al., 2014). The STs observed
in our study were reported by Izdebski et al. (2014) except
for ST110. Our study conﬁrms the ﬁndings of Izdebski et al.
(2014) showing that some E. cloacae lineages have an increased
epidemic potential and may participate to the spread of the
resistance to antibiotics, including carbapenems (with or without
carbapenemase genes).
The large clonal diversity of E. cloacae would be linked to
antibiotics pressure. Further studies might point out speciﬁc
factors (e.g., colonization, ability to infect more easily) explaining
these ﬁndings.
CONCLUSION
We combined here the molecular typing of carbapenem-non-
susceptible E. cloacae isolates with the characterization of FQ
resistance determinants. It will give new insights to the ﬁrst
multinational E. cloacae clonality study previously reported
(Izdebski et al., 2014).
The MLST study revealed that E. cloacae comprised a
large amount of lineages spreading in North-Eastern France.
Nonetheless, E. cloacae ST74 was the most widespread
ST, more often resistant to various antibiotics and carried
more often PMQR. Carbapenemase production was not
the major determinant leading to decrease susceptibility
to carbapenem. Nonetheless carbapenemase-producing
isolates carried the well-known IncL/M pOXA48a. In term
of FQ-R, E. cloacae isolates harbored a wide range of
pattern, from no substitution to multiple substitutions in
QRDR. qnr was the major PMQR determinant found in
E. cloacae.
These data underline, once again, the plausible role of the
antibiotic pressure, in emergence and persistence of carbapenem
and quinolones resistance genes.
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